000 01322 a2200409 4500
005 20250517080702.0
264 0 _c20170117
008 201701s 0 0 eng d
022 _a1530-9932
024 7 _a10.1208/s12249-016-0495-1
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aTakegami, Shigehiko
245 0 0 _aNone
_h[electronic resource]
260 _bAAPS PharmSciTech
_cDec 2016
300 _a1500-1506 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAntineoplastic Agents
_xchemistry
650 0 4 _aChemistry, Pharmaceutical
_xmethods
650 0 4 _aDrug Carriers
_xchemistry
650 0 4 _aEmulsions
_xchemistry
650 0 4 _aFlutamide
_xchemistry
650 0 4 _aHumans
650 0 4 _aImidazolidines
_xchemistry
650 0 4 _aLipids
_xchemistry
650 0 4 _aMagnetic Resonance Spectroscopy
650 0 4 _aMale
650 0 4 _aNanoparticles
_xchemistry
650 0 4 _aParticle Size
650 0 4 _aPhosphatidylcholines
_xchemistry
650 0 4 _aProstatic Neoplasms
_xdrug therapy
700 1 _aKitamura, Keisuke
700 1 _aOhsugi, Mayuko
700 1 _aKonishi, Atsuko
700 1 _aKitade, Tatsuya
773 0 _tAAPS PharmSciTech
_gvol. 17
_gno. 6
_gp. 1500-1506
856 4 0 _uhttps://doi.org/10.1208/s12249-016-0495-1
_zAvailable from publisher's website
999 _c25720591
_d25720591